Theralase Technologies (TSXV:TLT) Days Sales Outstanding : 17.55 (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Theralase Technologies Days Sales Outstanding?

Theralase Technologies's average Accounts Receivable for the three months ended in Dec. 2023 was C$0.07 Mil. Theralase Technologies's Revenue for the three months ended in Dec. 2023 was C$0.36 Mil. Hence, Theralase Technologies's Days Sales Outstanding for the three months ended in Dec. 2023 was 17.55.

The historical rank and industry rank for Theralase Technologies's Days Sales Outstanding or its related term are showing as below:

TSXV:TLT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.56 Med: 95.63 Max: 257.15
Current: 23.56

During the past 13 years, Theralase Technologies's highest Days Sales Outstanding was 257.15. The lowest was 23.56. And the median was 95.63.

TSXV:TLT's Days Sales Outstanding is ranked better than
93.71% of 811 companies
in the Medical Devices & Instruments industry
Industry Median: 65.11 vs TSXV:TLT: 23.56

Theralase Technologies's Days Sales Outstanding declined from Sep. 2022 (35.31) to Dec. 2023 (17.55).

Theralase Technologies Days Sales Outstanding Historical Data

The historical data trend for Theralase Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Days Sales Outstanding Chart

Theralase Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

238.92

257.15

179.46

54.16

28.82

Theralase Technologies Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															35.31	33.17	17.63	8.28	17.55

Competitive Comparison of Theralase Technologies's Days Sales Outstanding

For the Medical Devices subindustry, Theralase Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theralase Technologies's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's Days Sales Outstanding falls into.

Theralase Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Theralase Technologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.055	+	0.114)	/	2 )	/	1.07	*	365
=	0.0845					/	1.07	*	365
=	28.82

Theralase Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.026	+	0.114)	/	2 )	/	0.364	*	365 / 4
=	0.07					/	0.364	*	365 / 4
=	17.55

Theralase Technologies (TSXV:TLT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Theralase Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Theralase Technologies (TSXV:TLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (TSXV:TLT) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

TLTFF:USA

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.

Executives

Matthew Thomas Perraton

Director